(TVTX) – Hot New Coverage
-
Evercore ISI Resumes Travere Therapeutics (TVTX) at Outperform, 'sales of sparsentan in IgAN will begin to accelerate as we head into year end'
-
JPMorgan Starts Travere Therapeutics (TVTX) at Overweight
-
-
-
Back to TVTX Stock Lookup